A VC's take on the Genomic Age

Mohr Davidow Ventures partner Bill Ericson, who helped fund high-speed genome-sequencer Pacific Biosciences, is a big believer in the emerging Age of Genomics and its potential to transform medicine, health insurance and our understanding of ourselves.

Check out my recent Q&A with the venture capitalist over at VentureBeat Life Sciences for a conversation that also features digressions on the likelihood that we’ll end up living in a Gattaca-style dystopia and why most people taking cholesterol-lowering statins should chuck them instead.